RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
-18.69%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$714M
AUM Growth
+$714M
(-22%)
Cap. Flow
-$1.38M
Cap. Flow
% of AUM
-0.19%
Top 10 Holdings %
Top 10 Hldgs %
30.92%
Holding
97
New
3
Increased
39
Reduced
32
Closed
12
Top Buys
| 1 |
AbbVie
ABBV
|
$9.14M |
| 2 |
Zimmer Biomet
ZBH
|
$8.09M |
| 3 |
CVS Health
CVS
|
$7.11M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$6.66M |
| 5 |
UnitedHealth
UNH
|
$5.49M |
Top Sells
| 1 |
DERM
Dermira, Inc.
DERM
|
$12.1M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$10.7M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$10.1M |
| 4 |
Humana
HUM
|
$6.91M |
| 5 |
Becton Dickinson
BDX
|
$4.6M |
Sector Composition
| 1 | Healthcare | 96.22% |
| 2 | Energy | 0.06% |
| 3 | Technology | 0.03% |
| 4 | Financials | 0.02% |
| 5 | Consumer Discretionary | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Thermo Fisher Scientific
TMO
$183B
| $5.39M | 0.75% |
+19,000
| New | +$5.39M |
|
52
Adverum Biotechnologies
ADVM
$68.2M
| $5.37M | 0.75% |
550,000
-100,000
| -15% | -$977K |
|
53
Glaukos
GKOS
$5.42B
| $5.09M | 0.71% |
165,000
-70,000
| -30% | -$2.16M |
|
|
BHVN
54
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $4.76M | 0.67% |
140,000
+15,000
| +12% | +$510K |
|
55
Sangamo Therapeutics
SGMO
$161M
| $4.46M | 0.62% |
700,000
| – | – |
|
56
Agios Pharmaceuticals
AGIO
$2.36B
| $3.9M | 0.55% |
110,000
-50,000
| -31% | -$1.77M |
|
|
RDUS
57
DELISTED
Radius Health, Inc.
RDUS
| $3.84M | 0.54% |
295,000
+125,000
| +74% | +$1.63M |
|
58
Incyte
INCY
$17B
| $3.66M | 0.51% |
50,000
-15,000
| -23% | -$1.1M |
|
59
Dynavax Technologies
DVAX
$1.19B
| $3.53M | 0.49% |
1,000,000
-80,000
| -7% | -$282K |
|
60
MeiraGTx Holdings
MGTX
$590M
| $3.31M | 0.46% |
246,307
+55,007
| +29% | +$739K |
|
|
MNTA
61
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $3.3M | 0.46% |
121,400
-56,673
| -32% | -$1.54M |
|
|
RVNC
62
DELISTED
Revance Therapeutics, Inc.
RVNC
| $3.26M | 0.46% |
220,000
-30,000
| -12% | -$444K |
|
|
63
Becton Dickinson
BDX
$54.3B
| $3.22M | 0.45% |
14,000
-20,000
| -59% | -$4.6M |
|
|
STML
64
DELISTED
Stemline Therapeutics, Inc.
STML
| $3.15M | 0.44% |
650,000
-110,181
| -14% | -$533K |
|
65
uniQure
QURE
$954M
| $3.12M | 0.44% |
65,798
+5,798
| +10% | +$275K |
|
|
BLUE
66
DELISTED
bluebird bio
BLUE
| $3.08M | 0.43% |
67,000
+10,000
| +18% | +$460K |
|
67
Ultragenyx Pharmaceutical
RARE
$3.04B
| $3.05M | 0.43% |
+68,524
| New | +$3.05M |
|
|
GTHX
68
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $2.76M | 0.39% |
250,172
-13,228
| -5% | -$146K |
|
69
Rigel Pharmaceuticals
RIGL
$710M
| $2.71M | 0.38% |
1,736,176
-163,824
| -9% | -$256K |
|
70
Apellis Pharmaceuticals
APLS
$3.51B
| $2.68M | 0.38% |
100,000
+20,000
| +25% | +$536K |
|
|
ICPT
71
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.52M | 0.35% |
40,000
| – | – |
|
|
ONC
72
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
| $2.46M | 0.34% |
20,000
| – | – |
|
|
AIMT
73
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $2.38M | 0.33% |
165,000
+15,000
| +10% | +$216K |
|
|
AMRN
74
Amarin Corp
AMRN
$311M
| $2.2M | 0.31% |
550,000
+150,000
| +38% | +$600K |
|
|
VRAY
75
DELISTED
ViewRay, Inc.
VRAY
| $2.13M | 0.3% |
850,000
+100,000
| +13% | +$250K |
|